Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 37, Issue 1, 2013, Pages 109-125

  Lo, Adrian C ^a   Iscru, Emilia ^a   Blum, David ^b   Tesseur, Ina ^a,c   Callaerts Vegh, Zsuzsanna ^a   Buée, Luc ^b   De Strooper, Bart ^b,c   Balschun, Detlef ^a   D'Hooge, Rudi ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b INSERM   (France)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Alzheimer's disease; amyloid; cognition; prefrontal cortex; synaptic plasticity; tau

Indexed keywords

AMYLOID; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; AVERSION; BEHAVIOR; BRAIN ELECTROPHYSIOLOGY; BRAIN REGION; COGNITION; COMPARATIVE STUDY; DISCRIMINANT ANALYSIS; EXPLORATORY BEHAVIOR; FEAR; IMMUNOHISTOCHEMISTRY; LEARNING DISORDER; LONG TERM POTENTIATION; MENTAL PERFORMANCE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; OPEN FIELD TEST; PASSIVE AVOIDANCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECOGNITION; SPATIAL LEARNING; SPATIAL MEMORY; SYNAPTIC TRANSMISSION; TASK PERFORMANCE; TASTE AVERSION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONAL PLASTICITY; PLAQUE, AMYLOID; PREFRONTAL CORTEX; PRESENILIN-1; SYNAPSES; TAU PROTEINS;

EID: 84883145571     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-122296     Document Type: Article

References (89)

1. Mandelkow EM, Mandelkow E (1998) Tau in Alzheimer's disease. Trends Cell Biol 8, 425-427. (Pubitemid 28529713)
2. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791. (Pubitemid 35231524)
3. WalshDM,Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181-193. (Pubitemid 39348839)
4. Haass C (2004) Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J 23, 483-488. (Pubitemid 38282380)
5. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33, 95-130.
6. Jucker M, Walker LC (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70, 532-540.
7. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58, 1791-1800. (Pubitemid 34663580)
8. Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1, 213-216.
9. Backman L (1998) The link between knowledge and remembering in Alzheimer's disease. Scand J Psychol 39, 131-139. (Pubitemid 128471780)
10. Hoefer M, Allison SC, Schauer GF, Neuhaus JM, Hall J, Dang JN, Weiner MW, Miller BL, Rosen HJ (2008) Fear conditioning in frontotemporal lobar degeneration and Alzheimer's disease. Brain 131, 1646-1657. (Pubitemid 351806464)
11. Hailstone JC, Ridgway GR, Bartlett JW, Goll JC, Buckley AH, Crutch SJ, Warren JD (2011) Voice processing in dementia: A neuropsychological and neuroanatomical analysis. Brain 134, 2535-2547.
12. Van der Vlies AE, Verwey NA, Bouwman FH, Blankenstein MA, Klein M, Scheltens P, Van der Flier WM (2009) CSF biomarkers in relationship to cognitive profiles in Alzheimer disease. Neurology 72, 1056-1061.
13. Koric L, Felician O, Guedj E, Hubert AM, Mancini J, Boucraut J, Ceccaldi M (2010) Could clinical profile influence CSF biomarkers in early-onset Alzheimer disease? Alzheimer Dis Assoc Disord 24, 278-283.
14. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102. (Pubitemid 26332733)
15. Gotz J, Chen F, Barmettler R, Nitsch RM (2001) Tau filament formation in transgenic mice expressing P301L tau. J Biol Chem 276, 529-534. (Pubitemid 32050347)
16. Rockenstein E, Mallory M, Mante M, Sisk A, Masliaha E (2001) Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). J Neurosci Res 66, 573-582. (Pubitemid 33032326)
17. King DL, Arendash GW (2002) Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiol Behav 75, 627-642. (Pubitemid 34521825)
18. Brody DL, Holtzman DM (2006) Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury. Exp Neurol 197, 330-340. (Pubitemid 43077140)
19. Pennanen L, Wolfer DP, Nitsch RM, Gotz J (2006) Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice. Genes Brain Behav 5, 369-379. (Pubitemid 44000922)
20. Van der Jeugd A, Ahmed T, Burnouf S, Belarbi K, Hamdame M, Grosjean ME, Humez S, Balschun D, Blum D, Buee L, D'Hooge R (2011) Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission. Neurobiol Learn Mem 95, 296-304.
21. Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, Calhoun ME, Jaggi F, Wolburg H, Gengler S, Haass C, Ghetti B, Czech C, Holscher C, Mathews PM, Jucker M (2006) Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7, 940-946. (Pubitemid 44523975)
22. Schindowski K, Bretteville A, Leroy K, Begard S, Brion JP, Hamdane M, Buee L (2006) Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol 169, 599-616. (Pubitemid 44156317)
23. Schindowski K, Belarbi K, Bretteville A, Ando K, Buee L (2008) Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation. Genes Brain Behav 7(Suppl 1), 92-100.
24. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539. (Pubitemid 34288854)
25. Gengler S, Hamilton A, Holscher C (2010) Synaptic plasticity in the hippocampus of a APP/PS1 mouse model of Alzheimer's disease is impaired in old but not young mice. PLoS One 5, e9764.
26. Sydow A, Van der Jeugd A, Zheng F, Ahmed T, Balschun D, Petrova O, Drexler D, Zhou LP, Rune G, Mandelkow E, D'Hooge R, Alzheimer C, Mandelkow EM (2011) Tauinduced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic tau mutant. J Neurosci 31, 2511-2525.
27. Milad MR, Quirk GJ (2002) Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420, 70-74. (Pubitemid 35291441)
28. Brigman JL, Rothblat LA (2008) Stimulus specific deficit on visual reversal learning after lesions of medial prefrontal cortex in the mouse. Behav Brain Res 187, 405-410.
29. Scholtzova H, Wadghiri YZ, Douadi M, Sigurdsson EM, Li YS, Quartermain D, Banerjee P, Wisniewski T (2008) Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging. J Neurosci Res 86, 2784-2791.
30. Burnouf S, Martire A, Derisbourg M, Laurent C, Belarbi K, Leboucher A, Fernandez-Gomez FJ, Troquier L, Eddarkaoui S, Grosjean ME, Demeyer D, Muhr-Tailleux A, Buisson A, Sergeant N, Hamdane M, Humez S, Popoli P, Buee L, BlumD (2013) NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a tau transgenic model. Aging Cell 12, 11-23.
31. Filali M, Lalonde R, Rivest S (2011) Anomalies in social behaviors and exploratory activities in an APPswe/PS1 mouse model of Alzheimer's disease. Physiol Behav 104, 880-885.
32. Deacon RM, Koros E, Bornemann KD, Rawlins JN (2009) Aged Tg2576 mice are impaired on social memory and open field habituation tests. Behav Brain Res 197, 466-468.
33. Sanchez PE, Zhu L, Verret L, Vossel K a, Orr AG, Cirrito JR, Devidze N, Ho K, Yu G-Q, Palop JJ, Mucke L (2012) Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model. Proc Natl Acad Sci USA 109, E2895-903.
34. Goddyn H, Leo S, Meert T, D'Hooge R (2006) Differences in behavioural test battery performance between mice with hippocampal and cerebellar lesions. Behav Brain Res 173, 138-147. (Pubitemid 44604266)
35. Lo AC, Callaerts-Vegh Z, Nunes AF, Rodrigues CM, D'Hooge R (2013) Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice. Neurobiol Dis 50, 21-29.
36. Cheng PJ, Pai MC (2010) Dissociation between recognition of familiar scenes and of faces in patients with very mild Alzheimer disease: An event-related potential study. Clin Neurophysiol 121, 1519-1525.
37. Naert A, Callaerts-Vegh Z, D'Hooge R (2011) Nocturnal hyperactivity, increased social novelty preference and delayed extinction of fear responses in post-weaning socially isolated mice. Brain Res Bull 85, 354-362.
38. Nadler JJ, Moy SS, Dold G, Trang D, Simmons N, Perez A, Young NB, Barbaro RP, Piven J, Magnuson TR, Crawley JN (2004) Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav 3, 303-314. (Pubitemid 39277417)
39. Reiserer RS, Harrison FE, Syverud DC, McDonaldMP(2007) Impaired spatial learning in the APPSwe+PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. Genes Brain Behav 6, 54-65. (Pubitemid 46090333)
40. Adriani W, Ognibene E, Heuland E, Ghirardi O, Caprioli A, Laviola G (2006) Motor impulsivity in APP-SWE mice: A model of Alzheimer's disease. Behav Pharmacol 17, 525-533. (Pubitemid 44325815)
41. Blackshear AL, Xu W, Anderson M, Xu F, Previti ML, Van Nostrand WE, Robinson JK (2011) A novel operant testing regimen for multi-construct cognitive characterization of a murine model of Alzheimer's amyloid-related behavioral impairment. Neurobiol Learn Mem 96, 443-451.
42. Lagadec S, Rotureau L, Hemar A, Macrez N, Delcasso S, Jeantet Y, Cho YH (2010) Early temporal short-term memory deficits in double transgenic APP/PS1 mice. Neurobiol Aging 33, 203 e1-11.
43. Callaerts-Vegh Z, Beckers T, Ball SM, Baeyens F, Callaerts PF, Cryan JF, Molnar E, D'Hooge R (2006) Concomitant deficits in working memory and fear extinction are functionally dissociated from reduced anxiety in metabotropic glutamate receptor 7-deficient mice. J Neurosci 26, 6573-6582. (Pubitemid 44318338)
44. Quirk GJ, Garcia R, Gonzalez-Lima F (2006) Prefrontal mechanisms in extinction of conditioned fear. Biol Psychiatry 60, 337-343. (Pubitemid 44215848)
45. Belarbi K, Burnouf S, Fernandez-Gomez F-J, Laurent C, Lestavel S, Figeac M, Sultan A, Troquier L, Leboucher A, Caillierez R, Grosjean M-E, Demeyer D, Obriot H, Brion I, Barbot B, Galas M-C, Staels B, Humez S, Sergeant N, Schraen-Maschke S, Muhr-Tailleux A, Hamdane M, Búee L, Blum D (2011) Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology. Neurobiol Dis 43, 486-494.
46. Govindarajan N, Rao P, Burkhardt S, Sananbenesi F, Schluter OM, Bradke F, Lu J, FischerA(2012) ReducingHDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease. EMBO Mol Med 5, 52-63.
47. Lalonde R, Kim HD, Fukuchi K (2004) Exploratory activity, anxiety, and motor coordination in bigenic APPswe+ PS1/DeltaE9 mice. Neurosci Lett 369, 156-161. (Pubitemid 39265419)
48. Crabbe JC,Wahlsten D, Dudek BC (1999) Genetics of mouse behavior: Interactions with laboratory environment. Science 284, 1670-1672. (Pubitemid 29291377)
49. Van Gaalen MM, Steckler T (2000) Behavioural analysis of four mouse strains in an anxiety test battery. Behav Brain Res 115, 95-106.
50. Chen G, Chen KS, Knox J, Inglis J, Bernard A, Martin SJ, Justice A, McConlogue L, Games D, Freedman SB, Morris RG (2000) A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408, 975-979. (Pubitemid 32101643)
51. Polydoro M, Acker CM, Duff K, Castillo PE, Davies P (2009) Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. J Neurosci 29, 10741-10749.
52. Weintraub S,WicklundAH,SalmonDP(2012) The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med 2, a006171.
53. Flunkert S, Hierzer M, Loffler T, Rabl R, Neddens J, Duller S, Schofield EL,Ward MA, Posch M, Jungwirth H,Windisch M, Hutter-Paier B (2013) Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model. Neurodegener Dis 11, 194-205.
54. Wesson DW, Levy E, Nixon RA, Wilson DA (2010) Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model. J Neurosci 30, 505-514.
55. Bolander A, Kieser D, Voss C, Bauer S, Schon C, Burgold S, Bittner T, Holzer J, Heyny-von Haussen R, Mall G, Goetschy V, Czech C, Knust H, Berger R, Herms J, Hilger I, Schmidt B (2012) Bis(arylvinyl)pyrazines,-pyrimidines, and-pyridazines as imaging agents for tau fibrils and betaamyloid plaques in Alzheimer's disease models. J Med Chem 55, 9170-9180.
56. Van der Jeugd A, Blum D, Raison S, Eddarkaoui S, Buee L, D'Hooge R (2013) Observations in THY-Tau22 mice that resemble behavioral and psychological signs and symptoms of dementia. Behav Brain Res 242C, 34-39.
57. Vloeberghs E, Van Dam D, Coen K, Staufenbiel M, De Deyn PP (2006) Aggressive male APP23 mice modeling behavioral alterations in dementia. Behav Neurosci 120, 1380-1383. (Pubitemid 46058713)
58. Alexander G, Hanna A, SernaV,Younkin L,Younkin S, Janus C (2011) Increased aggression in males in transgenic Tg2576 mouse model of Alzheimer's disease. Behav Brain Res 216, 77-83.
59. McDonald RJ, Hong NS (2000) Rats with hippocampal damage are impaired on place learning in the water task when overtrained under constrained conditions. Hippocampus 10, 153-161. (Pubitemid 30216352)
60. Zhang M, Storm DR, Wang H (2011) Bidirectional synaptic plasticity and spatial memory flexibility require Ca2+-stimulated adenylyl cyclases. J Neurosci 31, 10174-10183.
61. Pistell PJ, Zhu M, Ingram DK (2008) Acquisition of conditioned taste aversion is impaired in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease. Neuroscience 152, 594-600.
62. Pennanen L,Welzl H, D'Adamo P, Nitsch RM, Gotz J (2004) Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice. Neurobiol Dis 15, 500-509. (Pubitemid 38435342)
63. King DL, Arendash GW, Crawford F, Sterk T, Menendez J, Mullan MJ (1999) Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behav Brain Res 103, 145-162. (Pubitemid 29417998)
64. Taniguchi T, Doe N, Matsuyama S, Kitamura Y, Mori H, Saito N, Tanaka C (2005) Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation. FEBS Lett 579, 5704-5712. (Pubitemid 41460490)
65. Deacon RM, Cholerton LL, Talbot K, Nair-Roberts RG, Sanderson DJ, Romberg C, Koros E, Bornemann KD, Rawlins JN (2008) Age-dependent and-independent behavioral deficits in Tg2576 mice. Behav Brain Res 189, 126-138.
66. Shiryaev N, Jouroukhin Y, Gozes I (2010) 3R tau expression modifies behavior in transgenic mice. J Neurosci Res 88, 2727-2735.
67. Welzl H, D'Adamo P, Lipp HP (2001) Conditioned taste aversion as a learning and memory paradigm. Behav Brain Res 125, 205-213. (Pubitemid 33000459)
68. Janus C, Welzl H, Hanna A, Lovasic L, Lane N, St George-Hyslop P, Westaway D (2004) Impaired conditioned taste aversion learning in APP transgenic mice. Neurobiol Aging 25, 1213-1219. (Pubitemid 39094024)
69. Yamamoto T (2007) Brain regions responsible for the expression of conditioned taste aversion in rats. Chem Senses 32, 105-109. (Pubitemid 46017880)
70. Herry C, Ciocchi S, Senn V, Demmou L, Muller C, Luthi A (2008) Switching on and off fear by distinct neuronal circuits. Nature 454, 600-606.
71. Hanna A, Horne P, Yager D, Eckman C, Eckman E, Janus C (2009) Amyloid beta and impairment in multiple memory systems in older transgenic APP TgCRND8 mice. Genes Brain Behav 8, 676-684.
72. Bienvenu TC, Busti D, Magill PJ, Ferraguti F, Capogna M (2012) Cell-type-specific recruitment of amygdala interneurons to hippocampal theta rhythm and noxious stimuli in vivo. Neuron 74, 1059-1074.
73. Battaglia F, Wang HY, Ghilardi MF, Gashi E, Quartarone A, Friedman E, Nixon RA (2007) Cortical plasticity in Alzheimer's disease in humans and rodents. Biol Psychiatry 62, 1405-1412. (Pubitemid 350180725)
74. Denayer E, Ahmed T, Brems H, Van Woerden G, Borgesius NZ, Callaerts-Vegh Z, Yoshimura A, Hartmann D, Elgersma Y, D'Hooge R, Legius E, Balschun D (2008) Spred1 is required for synaptic plasticity and hippocampus-dependent learning. J Neurosci 28, 14443-14449.
75. Larson J, Wong D, Lynch G (1986) Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation. Brain Res 368, 347-350. (Pubitemid 16046186)
76. Jay TM, Witter MP (1991) Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin. J Comp Neurol 313, 574-586.
77. McDonald AJ (1991) Organization of amygdaloid projections to the prefrontal cortex and associated striatum in the rat. Neuroscience 44, 1-14.
78. MiladMR,Vidal-Gonzalez I, Quirk GJ (2004) Electrical stimulation of medial prefrontal cortex reduces conditioned fear in a temporally specific manner. Behav Neurosci 118, 389-394. (Pubitemid 38445616)
79. Vertes RP (2004) Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse 51, 32-58. (Pubitemid 37421138)
80. Myers KM, Davis M (2007) Mechanisms of fear extinction. Mol Psychiatry 12, 120-150. (Pubitemid 46160979)
81. Lebron K, Milad MR, Quirk GJ (2004) Delayed recall of fear extinction in rats with lesions of ventral medial prefrontal cortex. Learn Mem 11, 544-548. (Pubitemid 39299702)
82. Pardon MC, Sarmad S, Rattray I, Bates TE, Scullion GA, Marsden CA, Barrett DA, Lowe J, Kendall DA (2009) Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels. Neurobiol Aging 30, 1099-1113.
83. Rattray I, Scullion GA, Soulby A, Kendall DA, Pardon MC (2009) The occurrence of a deficit in contextual fear extinction in adult amyloid-over-expressing TASTPM mice is independent of the strength of conditioning but can be prevented by mild novel cage stress. Behav Brain Res 200, 83-90.
84. Codita A, Gumucio A, Lannfelt L, Gellerfors P, Winblad B, Mohammed AH, Nilsson LN (2010) Impaired behavior of female tg-ArcSwe APP mice in the IntelliCage: A longitudinal study. Behav Brain Res 215, 83-94.
85. Bonardi C, De Pulford F, Jennings D, Pardon MC (2011) A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease. Behav Brain Res 222, 89-97.
86. Galsworthy MJ, Amrein I, Kuptsov PA, Poletaeva II, Zinn P, Rau A, Vyssotski A, Lipp HP (2005) A comparison of wild-caught wood mice and bank voles in the Intellicage: Assessing exploration, daily activity patterns and place learning paradigms. Behav Brain Res 157, 211-217. (Pubitemid 40082564)
87. Rapanelli M, Frick LR, Zanutto BS (2009) Differential gene expression in the rat hippocampus during learning of an operant conditioning task. Neuroscience 163, 1031-1038.
88. Featherstone RE, McDonald RJ (2004) Dorsal striatum and stimulus-response learning: Lesions of the dorsolateral, but not dorsomedial, striatum impair acquisition of a stimulus-response-based instrumental discrimination task, while sparing conditioned place preference learning. Neuroscience 124, 23-31. (Pubitemid 38186614)
89. Niv Y (2007) Cost, benefit, tonic, phasic: What do response rates tell us about dopamine and motivation? Ann N Y Acad Sci 1104, 357-376. (Pubitemid 47092744)